SNGX News and Press, Soligenix Inc. From 01/19/23

Soligenix Invited to Present at the Virtual Investor Summit Event PR Newswire Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market PRINCETON, N.J. , Jan. 19, 2023 /PRNewswire/ -- Soligenix,...

Company Seeks Approval for Reverse Stock Split to Maintain Nasdaq Listing   NEW YORK, NY - ( NewMediaWire ) - January 12, 2023 - PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (Nasdaq: SNGX) is on track to deliver a safe and effective front-line treatment to ...

Soligenix Announces Publication Demonstrating Positive Correlates of Protection with RiVax® in Non-Human Primate Survival after Ricin Challenge PR Newswire RiVax ® - Vaccinated NHP survival was statistically significantly correlated with an epitope-...

Soligenix Initiates Phase 2 Clinical Trial of SGX302 (synthetic hypericin) for the Treatment of Mild-to-Moderate Psoriasis PR Newswire Study HPN-PSR-01 opens patient enrollment PRINCETON, N.J. , Dec. 19, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are few things that get growth investors excited like the opportunity to invest in 10x stocks. By definition, these 10x stocks (also referred to as 10 baggers) can add huge gains to your portfolio. Plus, it just feels goo...

Soligenix Announces Submission of New Drug Application to the FDA for HyBryte™ in the Treatment of Cutaneous T-cell Lymphoma PR Newswire PRINCETON, N.J. , Dec. 15, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage...

Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program PR Newswire PRINCETON, N.J. , Nov. 15, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage...

Princeton, New Jersey--(Newsfile Corp. - November 11, 2022) - Investor Summit Group, today announced that Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company) will attend the Q4 Investor Summit live in NYC at the Sheraton Times Square. Jonathan Guarino, the Company's Senior Vice Presi...

Soligenix press release ( NASDAQ: SNGX ): Q3 GAAP EPS of -$0.08 beats by $0.01 . Revenue of $0.2M in-line (flat Y/Y). As of September 30, 2022, the Company's cash position was approximately $16.9 million. For further details see: Soligenix GAAP EPS of...

Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results PR Newswire PRINCETON, N.J. , Nov. 10, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...